Frontview REIT director Green buys $99,830 in stock

Published 24/03/2025, 18:02
Frontview REIT director Green buys $99,830 in stock

In a recent transaction, Robert S. Green, a director at FrontView REIT, Inc. (NASDAQ:FVR), acquired 7,450 shares of the company’s common stock. The timing is notable as InvestingPro data shows the stock has declined over 26% year-to-date, with technical indicators suggesting oversold conditions. The purchase, made on March 21, totaled $99,830, with shares bought at prices ranging from $13.34 to $13.43 each. The acquisition was executed through RSG Holdings Inc., an entity wholly owned by Green. Following this transaction, Green holds 7,450 shares indirectly. According to InvestingPro analysis, the stock appears undervalued, with analyst price targets ranging from $19 to $22. Discover more insights and 10+ additional ProTips for FVR in the comprehensive Pro Research Report, available exclusively to subscribers.

In other recent news, FrontView REIT Inc. reported its earnings for the fourth quarter of 2024. The company achieved an adjusted funds from operations (AFFO) per share of $0.33, in line with its guidance, while total revenue reached $15.51 million. Despite meeting AFFO expectations, FrontView REIT reported a net loss with earnings per share (EPS) of -$0.78, which fell below analysts’ expectations and contributed to investor concerns. The company maintained a robust occupancy rate of 98% and continued its acquisition strategy, adding $103.4 million in new assets during the quarter.

Looking forward, FrontView REIT has set its 2025 AFFO per share guidance between $1.20 and $1.26 and plans to acquire $175 million to $200 million in real estate. The company aims for a 7.5% cap rate on new acquisitions, which could enhance cash flow. During the earnings call, executives expressed confidence in managing tenant issues and highlighted ongoing negotiations for several vacant properties. Analysts from firms like Morgan Stanley (NYSE:MS) have inquired about the acquisition pipeline and tenant health, reflecting broader market interest in the company’s strategic direction.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.